• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

窦房结疾病、心房颤动和其他心脏疾病患者的缺血性脑卒中。

Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.

机构信息

From the Service de Cardiologie, Centre Hospitalier Universitaire Trousseau, Faculté de Médecine (A.B., A.B., J.H., N.C., D.B., L.F.), Université François Rabelais, Tours, France.

Service D'Information Médicale et d'Épidémiologie, Centre Hospitalier Universitaire et EA7505 (C.G., J.H.), Université François Rabelais, Tours, France.

出版信息

Stroke. 2020 Jun;51(6):1674-1681. doi: 10.1161/STROKEAHA.120.029048. Epub 2020 May 11.

DOI:10.1161/STROKEAHA.120.029048
PMID:32390547
Abstract

Background and Purpose- Atrial fibrillation (AF) is known to increase risk of ischemic stroke (IS), but the risk of IS in isolated sinus node disease (SND) is unclear. We compared the incidence of IS in patients with SND, patients with AF, and in a control population with other cardiac diseases (disease of the circulatory system using the ). Methods- This French longitudinal cohort study was based on the national database covering hospital care for the entire population from 2008 to 2015. Results- Of 1 692 157 patients included in the cohort, 100 366 had isolated SND, 1 564 270 had isolated AF, and 27 521 had AF associated with SND. Incidence of IS during follow-up was higher in isolated patients with AF than in AF associated with SND (yearly rate 2.22% versus 2.06%) and in isolated patients with AF than in isolated patients with SND (yearly rate 2.22% versus 1.59%). The incidence of IS was lower in a control population with other cardiac conditions (n=479 108) compared with SND and patients with AF (0.96%/y, 1.59%/y, and 2.22%/y, respectively). After 1:1 propensity score matching, SND was associated with lower incidence of IS compared to AF (hazard ratio, 0.77 [95% CI, 0.73-0.82]) but higher incidence of IS compared to control population (hazard ratio, 1.27 [95%CI, 1.19-1.35]). Conclusions- Patients with SND had a lower risk of thromboembolic events than patients with AF but a higher risk than a control population with other cardiac diseases. Randomized clinical trial in a selected SND population, with, for example, a high CHADS-VASc score, would be required to determine the value of IS prevention by anticoagulation.

摘要

背景与目的-已知心房颤动(AF)会增加缺血性卒中(IS)的风险,但孤立性窦房结疾病(SND)患者发生 IS 的风险尚不清楚。我们比较了 SND 患者、AF 患者和患有其他心脏疾病(心血管疾病)的对照组患者的 IS 发生率。方法-这项法国纵向队列研究基于涵盖 2008 年至 2015 年期间全人群住院治疗的国家数据库。结果-在纳入的 1692157 例患者中,100366 例患者为孤立性 SND,1564270 例患者为孤立性 AF,27521 例患者为 AF 合并 SND。随访期间,孤立性 AF 患者的 IS 发生率高于 AF 合并 SND 患者(年发生率分别为 2.22%和 2.06%),也高于孤立性 SND 患者(年发生率分别为 2.22%和 1.59%)。患有其他心脏疾病(n=479108)的对照组患者的 IS 发生率低于 SND 和 AF 患者(分别为 0.96%/y、1.59%/y 和 2.22%/y)。经 1:1 倾向评分匹配后,SND 患者发生 IS 的风险较 AF 患者低(风险比,0.77[95%CI,0.73-0.82]),但较对照组患者高(风险比,1.27[95%CI,1.19-1.35])。结论-与 AF 患者相比,SND 患者发生血栓栓塞事件的风险较低,但与患有其他心脏疾病的对照组患者相比,其发生风险较高。需要在选择的 SND 患者人群中开展随机临床试验,例如 CHADS-VASc 评分较高的患者,以确定抗凝预防 IS 的价值。

相似文献

1
Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.窦房结疾病、心房颤动和其他心脏疾病患者的缺血性脑卒中。
Stroke. 2020 Jun;51(6):1674-1681. doi: 10.1161/STROKEAHA.120.029048. Epub 2020 May 11.
2
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
3
Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism.非瓣膜性心房颤动伴或不伴临床甲状腺功能亢进症患者的血栓栓塞风险。
Glob Heart. 2021 Jun 17;16(1):45. doi: 10.5334/gh.871.
4
Sinus node dysfunction and stroke risk: a systematic review and meta-analysis.窦房结功能障碍与卒中风险:系统评价和荟萃分析。
BMJ Open. 2023 Nov 17;13(11):e076499. doi: 10.1136/bmjopen-2023-076499.
5
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
6
Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.缺血性中风与新发房颤患者:一项全国性队列研究。
Stroke. 2015 Sep;46(9):2432-7. doi: 10.1161/STROKEAHA.115.010270. Epub 2015 Aug 6.
7
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
8
Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation.与孤立性心房颤动相比,患有结构性心脏病或窦房结功能障碍的心房颤动患者的心房有效不应期延长。
Pacing Clin Electrophysiol. 2013 Feb;36(2):163-71. doi: 10.1111/pace.12037. Epub 2012 Nov 4.
9
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.窦房结功能障碍与更高的症状负担和更多的合并症相关:ORBIT-AF注册研究结果
Clin Cardiol. 2016 Feb;39(2):119-25. doi: 10.1002/clc.22504. Epub 2015 Dec 31.
10
CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.CHA2DS2-VAS(C)评分和 CHADS2 评分可预测起搏器和窦房结功能障碍患者的不良临床事件,与房颤无关。
Can J Cardiol. 2015 Aug;31(8):1004-11. doi: 10.1016/j.cjca.2015.02.020. Epub 2015 Feb 20.

引用本文的文献

1
Comparison of clinical outcomes between catheter ablation and permanent pacemaker implantation in Tachycardia-Bradycardia Syndrome patients: a meta-analysis.导管消融与永久性起搏器植入治疗心动过速-心动过缓综合征患者的临床结局比较:一项荟萃分析。
Int J Cardiol Heart Vasc. 2025 Aug 11;60:101767. doi: 10.1016/j.ijcha.2025.101767. eCollection 2025 Oct.
2
Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors.胰高血糖素样肽-1受体类似物和二肽基肽酶-4抑制剂潜在心脏代谢效应的分子见解
Int J Mol Sci. 2025 Jul 15;26(14):6777. doi: 10.3390/ijms26146777.
3
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
4
Mitochondrial dysfunction is a key link involved in the pathogenesis of sick sinus syndrome: a review.线粒体功能障碍是病态窦房结综合征发病机制中的关键环节:综述
Front Cardiovasc Med. 2024 Oct 29;11:1488207. doi: 10.3389/fcvm.2024.1488207. eCollection 2024.
5
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
6
Sinus node dysfunction and stroke risk: a systematic review and meta-analysis.窦房结功能障碍与卒中风险:系统评价和荟萃分析。
BMJ Open. 2023 Nov 17;13(11):e076499. doi: 10.1136/bmjopen-2023-076499.
7
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
8
Trends in research on sick sinus syndrome: A bibliometric analysis from 2000 to 2022.病态窦房结综合征的研究趋势:2000年至2022年的文献计量分析
Front Cardiovasc Med. 2022 Nov 9;9:991503. doi: 10.3389/fcvm.2022.991503. eCollection 2022.
9
Amateur Athlete with Sinus Arrest and Severe Bradycardia Diagnosed through a Heart Rate Monitor: A Six-Year Observation-The Necessity of Shared Decision-Making in Heart Rhythm Therapy Management.通过心率监测器诊断出患有窦性停搏和严重心动过缓的业余运动员:六年观察——心律治疗管理中共同决策的必要性。
Int J Environ Res Public Health. 2022 Aug 19;19(16):10367. doi: 10.3390/ijerph191610367.
10
Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study.无导线或传统经静脉心室永久起搏器:全国匹配对照研究。
J Am Heart Assoc. 2022 Aug 16;11(16):e025339. doi: 10.1161/JAHA.122.025339. Epub 2022 Aug 5.